Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Daxor
Oak Ridge, Tennessee, USAdaxor.com ↗
- Ownership
- Public · DXR
- Employees
- ~25
- Development stage
- Other
01
Overview
Daxor’s BVA‑100™ Blood Volume Analyzer has been FDA-cleared and used in over 65,000 tests. Clinical studies have demonstrated improved patient outcomes through accurate blood volume measurement for fluid management across heart failure, critical care, sepsis/ARDS, syncope, and surgical settings. Ongoing development includes a rapid point-of-care version for both military and civilian use.
- Therapeutic areas
- OtherHematologyCritical CareCardiovascular
- Modalities
- DeviceDiagnostic test (Blood Volume Analyzer)
- Industry
- Physiological Monitoring
02
Partnerships
U.S. Army/DOD SBIR program for POC device developmentValue Initiative Industry Alliance Partner with SNMMIclinical collaborations with major academic centers including Columbia University, Duke Health, Geisinger, Mayo Clinic, NYU Langone Health/Yale/Vanderbilt/Virginia Commonwealth University
03
Financials
- Market cap
- $50.4M
- Total revenue
- $503.4K
- Enterprise value
- $44.6M
Beyond the preview
Go deeper on Daxor.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Daxor.